Novo CEO Faces Sanders Over GLP-1 Drug Prices. All of Pharma Should Tune In.
- Posted on September 23, 2024
- By The Wall Street Journal
- 1 Views
Novo CEO Faces Sanders Over GLP-1 Drug Prices. All of Pharma Should Tune In.
Novo CEO Faces Sanders Over GLP-1 Drug Prices. All of Pharma Should Tune In. continue reading...